Details of the Drug

General Information of Drug (ID: DMURMY1)

Drug Name
Isoxsuprine
Indication
Disease Entry ICD 11 Status REF
Raynaud disease BD42.0 Approved [1]
Cerebrovascular disease 8B2Z Withdrawn from market [2]
Vascular disease BE2Z Investigative [3]
ATC Code
C04AA01: Isoxsuprine
C04AA: 2-amino-1-phenylethanol derivatives
C04A: PERIPHERAL VASODILATORS
C04: PERIPHERAL VASODILATORS
C: CARDIOVASCULAR SYSTEM
C04AA01: Isoxsuprine
C04AA: 2-amino-1-phenylethanol derivatives
C04A: PERIPHERAL VASODILATORS
C04: PERIPHERAL VASODILATORS
C: CARDIOVASCULAR SYSTEM
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C18H23NO3
Canonical SMILES
CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O
InChI
InChI=1S/C18H23NO3/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15/h3-11,13-14,18-21H,12H2,1-2H3
InChIKey
BMUKKTUHUDJSNZ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
3783
ChEBI ID
CHEMBL91855
CAS Number
395-28-8
UNII
R15UI3245N
DrugBank ID
DB08941
TTD ID
D0O8OB
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon. Eur J Clin Pharmacol. 1981;20(5):329-33.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Prognostic value of initial blood viscosity on vascular surgery and treatment in peripheral disease. Angiology. 1981 Apr;32(4):230-5.